New York State Common Retirement Fund’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,882
Closed -$485K 3449
2024
Q1
$485K Sell
13,882
-18
-0.1% -$656 ﹤0.01% 2089
2023
Q4
$528K Sell
13,900
-59
-0.4% -$1.26K ﹤0.01% 2077
2023
Q3
$256K Buy
13,959
+115
+0.8% +$2.41K ﹤0.01% 2316
2023
Q2
$359K Sell
13,844
-6,736
-33% -$157K ﹤0.01% 2242
2023
Q1
$388K Buy
20,580
+440
+2% +$10.2K ﹤0.01% 2301
2022
Q4
$496K Sell
20,140
-17
-0.1% -$500 ﹤0.01% 2311
2022
Q3
$362K Sell
20,157
-1,506
-7% -$27.1K ﹤0.01% 2499
2022
Q2
$246K Buy
21,663
+1,533
+8% +$22.6K ﹤0.01% 2697
2022
Q1
$448K Buy
20,130
+3
+0% +$77 ﹤0.01% 2455
2021
Q4
$879K Sell
20,127
-75
-0.4% -$3K ﹤0.01% 2158
2021
Q3
$673K Sell
20,202
-3,761
-16% -$114K ﹤0.01% 2310
2021
Q2
$659K Buy
23,963
+16,663
+228% +$347K ﹤0.01% 2447
2021
Q1
$147K Buy
7,300
+2,600
+55% +$75.9K ﹤0.01% 2944
2020
Q4
$155K Buy
+4,700
New +$125K ﹤0.01% 2838

Other funds holding INBX

New York State Common Retirement Fund's INBX Position: Q2 2024 in Review

New York State Common Retirement Fund sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 13,882 shares — an estimated $485K sold.

New York State Common Retirement Fund first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $879K in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • New York State Common Retirement Fund reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 13,882 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $485K.
  • New York State Common Retirement Fund first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • New York State Common Retirement Fund's Inhibrx, Inc. Common Stock position peaked at $879K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on New York State Common Retirement Fund's 13F filing for Q2 2024, filed 31 Jul 2024.